Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more


NL4-3 mCherry Luciferase Citations (9)

Originally described in: A flexible model of HIV-1 latency permitting evaluation of many primary CD4 T-cell reservoirs.
Lassen KG, Hebbeler AM, Bhattacharyya D, Lobritz MA, Greene WC PLoS One. 2012;7(1):e30176. doi: 10.1371/journal.pone.0030176. Epub 2012 Jan 24.
PubMed Journal

Articles Citing NL4-3 mCherry Luciferase

Nuclear RNA surveillance complexes silence HIV-1 transcription. Contreras X, Salifou K, Sanchez G, Helsmoortel M, Beyne E, Bluy L, Pelletier S, Rousset E, Rouquier S, Kiernan R. PLoS Pathog. 2018 Mar 19;14(3):e1006950. doi: 10.1371/journal.ppat.1006950. eCollection 2018 Mar. PubMed
Selection, Expansion, and Unique Pretreatment of Allogeneic Human Natural Killer Cells with Anti-CD38 Monoclonal Antibody for Efficient Multiple Myeloma Treatment. Motais B, Charvatova S, Walek Z, Hrdinka M, Smolarczyk R, Cichon T, Czapla J, Giebel S, Simicek M, Jelinek T, Sevcikova T, Sobotka J, Koristek Z, Hajek R, Bago JR. Cells. 2021 Apr 21;10(5). pii: cells10050967. doi: 10.3390/cells10050967. PubMed
Heparan Sulfate Facilitates Spike Protein-Mediated SARS-CoV-2 Host Cell Invasion and Contributes to Increased Infection of SARS-CoV-2 G614 Mutant and in Lung Cancer. Yue J, Jin W, Yang H, Faulkner J, Song X, Qiu H, Teng M, Azadi P, Zhang F, Linhardt RJ, Wang L. Front Mol Biosci. 2021 Jun 11;8:649575. doi: 10.3389/fmolb.2021.649575. eCollection 2021. PubMed
Neutralizing Antibodies to SARS-CoV-2 Selected from a Human Antibody Library Constructed Decades Ago. Qiang M, Ma P, Li Y, Liu H, Harding A, Min C, Wang F, Liu L, Yuan M, Ji Q, Tao P, Shi X, Li Z, Li T, Wang X, Zhang Y, Wu NC, Lee CD, Zhu X, Gilbert-Jaramillo J, Zhang C, Saxena A, Huang X, Wang H, James W, Dwek RA, Wilson IA, Yang G, Lerner RA. Adv Sci (Weinh). 2022 Jan;9(1):e2102181. doi: 10.1002/advs.202102181. Epub 2021 Oct 29. PubMed
Developing an Effective Peptide-Based Vaccine for COVID-19: Preliminary Studies in Mice Models. Yang H, Cao J, Lin X, Yue J, Zieneldien T, Kim J, Wang L, Fang J, Huang RP, Bai Y, Sneed K, Cao C. Viruses. 2022 Feb 22;14(3). pii: v14030449. doi: 10.3390/v14030449. PubMed
Monospecific and bispecific monoclonal SARS-CoV-2 neutralizing antibodies that maintain potency against B.1.617. Peng L, Hu Y, Mankowski MC, Ren P, Chen RE, Wei J, Zhao M, Li T, Tripler T, Ye L, Chow RD, Fang Z, Wu C, Dong MB, Cook M, Wang G, Clark P, Nelson B, Klein D, Sutton R, Diamond MS, Wilen CB, Xiong Y, Chen S. Nat Commun. 2022 Mar 28;13(1):1638. doi: 10.1038/s41467-022-29288-3. PubMed

Associated Plasmids

SARS-CoV-2 pan-variant inhibitory peptides deter S1-ACE2 interaction and neutralize delta and omicron pseudoviruses. Shah M, Ung Moon S, Hyun Kim J, Thanh Thao T, Goo Woo H. Comput Struct Biotechnol J. 2022;20:2042-2056. doi: 10.1016/j.csbj.2022.04.030. Epub 2022 Apr 26. PubMed
Production and characterization of lentivirus vector-based SARS-CoV-2 pseudoviruses with dual reporters: Evaluation of anti-SARS-CoV-2 viral effect of Korean Red Ginseng. Moon J, Jung Y, Moon S, Hwang J, Kim S, Kim MS, Yoon JH, Kim K, Park Y, Cho JY, Kweon DH. J Ginseng Res. 2023 Jan;47(1):123-132. doi: 10.1016/j.jgr.2022.07.003. Epub 2022 Jul 15. PubMed
Novel Local "Off-the-Shelf" Immunotherapy for the Treatment of Myeloma Bone Disease. Charvatova S, Motais B, Czapla J, Cichon T, Smolarczyk R, Walek Z, Giebel S, Hajek R, Bago JR. Cells. 2023 Jan 30;12(3):448. doi: 10.3390/cells12030448. PubMed

If you have published an article using this material, please email us at [email protected] to have your article added to this page.